|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Olmesartan#Overdosage]] |
| {{Olmesartan}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Overdosage==
| |
| | |
| Limited data are available related to overdosage in humans. The most likely manifestations of overdosage would be [[hypotension]] and [[tachycardia]]; [[bradycardia]] could be encountered if parasympathetic (vagal) stimulation occurs. If symptomatic [[hypotension]]occurs, initiate supportive treatment. The dialyzability of olmesartan is unknown.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BENICAR (OLMESARTAN MEDOXOMIL) TABLET, FILM COATED [DAIICHI SANKYO, INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33770d80-754f-11de-8dba-0002a5d5c51b | publisher = | date = | accessdate = 21 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{Angiotensin II receptor antagonists}}
| |
| | |
| [[Category:Angiotensin II receptor antagonists]]
| |
| [[Category:Imidazoles]]
| |
| [[Category:Tetrazoles]]
| |
| [[Category:Carboxylate esters]]
| |
| [[Category:Alcohols]]
| |
| [[Category:Biphenyls]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |